SearchGPT has the potential to fundamentally change how people seek and discover information. For pharma companies, failing ...

A new biotech start-up – Ouro Medicines – launched today with $120 million in funding from a Series A and a plan to develop ...

Researchers in the US have shown that an artificial intelligence algorithm trained to analyse video recordings of sleep tests ...

In October, Intellia reported phase 2 results with NTLA-2002 – which is pitching to become the first approved in vivo CRISPR ...

A major population proteomics study using UK Biobank patient samples backed by 14 pharma companies has launched today with ...

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...

Grifols has filed for US approval of a new drug for rare bleeding disorder acquired fibrinogen deficiency (AFD), which ...

Through a series of position papers, the EFPIA representing brandname drugmakers, self-medication group organisation AESGP, and Medicines for Europe – which represents the generic pharma industry – ...

Bioanalysis is also used to monitor therapeutic responses by evaluating drug levels, biomarkers, and physiological changes ...

In pharmaphorum’s inaugural Life Sciences Industry Report 2025, delve into the trends that propelled the pharmaceutical ...

As pharmaceutical companies increasingly rely on artificial intelligence (AI) to optimise trial processes, the potential for AI models to drift over time poses significant risks to trial integrity ...

Pfizer has partnered with a ‘computation-driven’ pharmaceutical technology company to develop a drug discovery platform powered by artificial intelligence (AI). Its collaboration with ...